Womens Health
-
Four Major Endometrial Cancer Trials Leave Chemotherapy’s Necessity Untested in dMMR Patients
RUBY, NRG-GY018, AtTEnd, and DUO-E4 all added immunotherapy to chemo backbones but omitted an immunotherapy-only arm, leaving dMMR patients exposed to potentially…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
-
Pioneering pharmacologist honored for breast cancer breakthrough
WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Actress Lisa Faulkner reveals early-stage breast cancer after routine mammogram
One woman in the UK receives a breast cancer diagnosis every ten minutes. That statistic, from research charity Breast Cancer Now, is…
-
Menopause Hormone Therapy Linked to 69% Lower Risk of Low Bone Density
CHICAGO — New research presented Sunday at the Endocrine Society’s annual meeting is forcing a strategic recalculation of how doctors and patients…
-
Six women in ICU after C-sections at Bikaner hospital; families await answers
The six women who underwent caesarean sections at PBM Hospital in Bikaner are now on dialysis, fighting kidney complications in the intensive…
-
Bikaner Hospital Probe Widens After First Death Among Six Women With Kidney Failure
Bikaner C-Section Complications: A System Under Scrutiny Six women are in intensive care in Bikaner. Their kidneys are failing after caesarean deliveries…
-
FDA Approves New Oral Pill Zuranolone for Postpartum Depression
On August 15, 2023, the United States Food and Drug Administration granted approval to Zuranolone, a medication that will be marketed under…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
Pandemic Disruptions Drove Excess Breast Cancer and Leukaemia Deaths Across 54 Nations
-
WHO Cervical Cancer Elimination Strategy Hinges on Closing U.S. HPV Vaccination Gaps
-
Navigating Standard-of-Care Options in Advanced HNSCC
-
Four Major Endometrial Cancer Trials Leave Chemotherapy’s Necessity Untested in dMMR Patients
-
Measles in the U.S.: Why Unvaccinated People Face Deadly Risks Now
-
How Plaid and Google’s Account Linking Partnership Reshapes Digital Banking
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992









